You are here: Industry Insights > Breckenridge

News List

Natco gets US FDA approval for Carfilzomib vials expresspharma
June 16, 2021
The parties have received final approval for 10 mg and 60 mg strengths of the product and tentative approval for 30 mg strength of the product.
Breckenridge Receives ANDA Approval for Asenapine Sublingual Tablets americanpharmaceuticalreview
March 12, 2021
Breckenridge Pharmaceutical announced the U.S. Food and Drug Administration (FDA)has granted final approval of its Abbreviated New Drug Application (ANDA) for Asenapine Sublingual Tablets in 5mg strength (generic for Saphris®).
Breckenridge Announces Final Approval of ANDA for Rivastigmine Transdermal System americanpharmaceuticalreview
December 30, 2019
Breckenridge Pharmaceutical announced the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application for ...
Panacea Biotec inks Tripartite agreement with Natco Pharma, Breckenridge Pharmaceutical expressbpd
August 30, 2018
Panacea Biotec, one of the India’s leading research based pharmaceutical and biotechnology companies, has entered into a tripartite agreement with Natco Pharma and Breckenridge Pharmaceutical.......
Breckenridge announces approval of Hep B virus tablets biospectrumasia
April 03, 2018
The product is manufactured by RA Chem Pharma Limited and supplied to Breckenridge for exclusive distribution in the United States.
Breckenridge Pharmaceutical, Inc. Announces Final Approval of its ANDA Entecavir tablets (Baraclude®) biospace
March 28, 2018
Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has granted final approval
Breckenridge Announces Final ANDA Approval for Azacitidine for Injection americanpharmaceuticalreview
June 27, 2017
Breckenridge Pharmaceutical announced the FDA has granted final approval of its ANDA Azacitidine for Injection, 100mg per vial, Single-Dose Vial, a generic version of Vidaza by Celgene Corporation.